PLBY Q3 Revenue Up 9%, Adjusted EBITDA Nearly Doubles on Honey Birdette and China Licensing Strength

What happened

PLBY Group reported third-quarter revenue growth of 9%, driven by strong performance at Honey Birdette and a rebound in China licensing. Adjusted EBITDA nearly doubled year-over-year, reflecting improved gross margins and operating leverage in the asset-light licensing model. The company continues to benefit from the $20 million annual minimum guarantee from Byborg, which provided stable royalty income, while new licensing deals and China recovery added incremental upside. However, litigation expenses remained elevated at approximately $2.5 million for the quarter, and the balance sheet continues to carry substantial net debt of around $171 million against minimal equity. The results support the turnaround narrative but do not yet resolve the overhangs of debt reduction, arbitration collection, and the durability of ex-Byborg licensing growth.

Implication

Over the longer term, investors should monitor whether the revenue growth and EBITDA improvement translate into sustained free cash flow and deleveraging. The Honey Birdette margin gains need to be maintained without heavy promotions, and China licensing must show continued collections and growth beyond the current quarter. The $81 million arbitration award remains uncollected, and its realization would be a significant catalyst. If the company can reduce net debt and litigation costs normalize, the equity could re-rate higher. Conversely, any reversal in licensing partner performance or a stall in deleveraging would expose the stock to further downside given the thin margin of safety.

Thesis delta

The latest quarter's revenue and EBITDA beat align with the bull case of a licensing-led recovery, but the core thesis of 'POTENTIAL SELL' due to fragile balance sheet and concentration risks remains largely unchanged. The improved profitability reduces near-term bankruptcy risk but does not yet justify a multiple expansion given the still-negative interest coverage and dependence on a few counterparties. We maintain a cautious stance pending evidence of sustained free-cash-flow generation and successful collection of the China arbitration award.